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Abstract
Background: Feline hyperthyroidism, the most common endocrinopathy in older cats, provides a spontaneous
model for human thyrotoxicosis. Human thyrotoxicosis is associated with redox unbalance, which may result in
organ damage. The redox status of hyperthyroid cats is largely unknown. The aims of the present study were to
compare the redox status of cats with hyperthyroidism with that of healthy cats and cats with chronic non-
thyroidal illness.
Results: Forty cats with untreated hyperthyroidism (group H), 45 chronically ill cats with non-thyroidal illness (group I),
and 39 healthy cats (group C) were recruited for this observational cross-sectional study. All cats were screened for
redox status markers. Determinable reactive oxygen metabolites (d-ROMs) were used as oxidative stress markers.
Antioxidant status was determined using the OXY-Adsorbent test to quantify the plasma barrier to oxidation. The
Oxidative Stress index (OSi) was calculated as the ratio of d-ROMs and OXY-Adsorbent test values. Data were compared
by ANOVA with Tukey’s multiple comparisons post-hoc test. The dROMs of group H (193 ± 47 CarrU) were significantly
higher (p < 0.001) than those of the healthy cats (103 ± 17 CarrU). The OXY-Adsorbent test results in group H (265 ±
68 μmol HClO/ml) were significantly lower than those in healthy cats (390 ± 83 μmol HClO/ml; p < 0.01) and chronically
ill cats (306 ± 45 μmol HClO/ml, p < 0.05). Moreover, the Osi value in group H (0.8 ± 0.2 CarrU/μmol HClO/ml) was
significantly higher (p < 0.001) than that of the healthy cats (0.3 ± 0.1 CarrU/μmol HClO/ml).
Conclusions: As described in humans with hyperthyroidism, feline hyperthyroidism is associated with redox
unbalance. Free radical production is increased in hyperthyroid cats and their antioxidant depletion seems to be more
severe than in cats with non-thyroidal illnesses. Our results support the rationale for a clinical trial investigating the
potential positive effects of antioxidant supplementation to cats with hyperthyroidism.
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Background
Feline hyperthyroidism (FH) is the most common endo-
crinopathy in middle-aged and geriatric cats [1, 2]. Hyper-
thyroid cats and humans share clinical, pathological, and
therapeutic features. Feline hyperthyroidism most often
results from benign adenomatous nodules of the thyroid
tissue, making it pathologically similar to Plummer’s
disease (toxic nodular goitre) in humans. It also resembles
Basedow-Graves’ disease in clinical appearance and
therapy [3].
In hyperthyroid cats, pharmacotherapy with thyroid per-
oxidase inhibitors, so-called anti-thyroid drugs, is often
the sole treatment option when radioiodine therapy is un-
available or when concurrent geriatric problems are likely
to increase the risk of anesthesia-related complications of
thyroidectomy [4]. Side-effects are a well-known compli-
cation in cats treated with anti-thyrotoxic agents [5, 6].
Redox unbalance, defined as a disturbance in the balance
between the production of free radicals (oxidative stress)
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and antioxidant defences (antioxidant status), is well docu-
mented in human patients and experimental animals with
hyperthyroidism [7–9]. Metabolic oxidation (associated
with the hypermetabolic state) has been postulated as the
origin of signs and symptoms of hyperthyroidism in
humans [10–13]. Furthermore, redox unbalance is consid-
ered a risk factor for idiosyncratic drug toxicity syndromes
in both humans and animal models [14–16]. Studies on
hyperthyroid patients show that oxidative stress markers
normalize after treatment and return to a euthyroid state
[10, 16], while the occurrence of drug-related side-effects
can be reduced with the concurrent administration of anti-
oxidants [12, 13].
Redox unbalance has been detected in various illnesses
in cats, including liver disease [17], FIV infection [18],
chronic kidney disease [19–22], and cardiac disease [23].
Studies investigating oxidative stress and antioxidant sta-
tus in hyperthyroid cats are scarce [24, 25].
The level of redox unbalance can be estimated by de-
termining markers for oxidative stress and antioxidant
status. Determinable reactive oxygen metabolites
(d-ROMs) can be used as an indicator of free radical
production and as a marker for oxidative stress, as well.
Antioxidant status can be determined using the
OXY-Adsorbent Test to quantify the plasma barrier to
oxidation. The Oxidative Stress index (OSi), a measure
that takes into account both oxidative stress and antioxi-
dant status, is calculated by the ratio of the d-ROMs test
result to the OXY-Adsorbent test result [26, 27].
The aims of the present study were to evaluate the
redox status in FH and to compare the oxidative risk of
the hyperthyroid population to that of healthy cats and
cats with chronic non-thyroidal illness.
Methods
Cats
The study was approved by the local ethical committee
and a written informed consent was obtained from all
cat owners. For this observational cross-sectional study,
cats presented to the Veterinary University Hospital of
the Department of Veterinary Science (University of
Turin, Italy) and other partner clinics and practices
throughout northern Italy, from November 2016 to
September 2017, were allocated in three groups. Group
H comprised cats with spontaneous, untreated hyperthy-
roidism. Group I included cats with chronic
non-thyroidal illness. Group C was composed of healthy
cats. Only indoor cats older than 6 years of age (i.e. ma-
ture, senior and geriatric cats) were included in the
study. The cats were categorized as hyperthyroid, chron-
ically ill or healthy according to their history, physical
examination, results of complete blood biochemical pro-
file, urinalysis, serum total thyroxine (TT4) concentra-
tion, thoracic radiographic findings, and abdominal and/
or cardiac ultrasound when deemed necessary for diag-
nosis. Body condition score (BCS) was measured accord-
ing to the 1–9 WSAVA point-scale [28]. Chronically ill
cats had to be newly-diagnosed with an infectious/in-
flammatory conditions, a metabolic diseases, a neoplasia
or with chronic kidney disease (CKD, IRIS Stage ≥2) and
had to show clinical signs for at least 3 weeks [29].
Hyperthyroid cats with a concurrent systemic disease
such as congestive heart failure, symptomatic renal fail-
ure (IRIS Stage 3 or 4, creatinine > 2.9 mg/dL; [29]), sys-
temic neoplasia, chronic liver disease, immune-mediated
disease, or systemic infection, any of which could influ-
ence antioxidant status independently of thyroid status,
were excluded from this study; as were cats treated with
antioxidants and/or methimazole within the last 3
months, fed with iodine-restricted food or a commercial
diet enriched with patented antioxidant formula, or sus-
pected of having nutritional deficiencies or excesses.
Analytic procedures and redox balance assessment
All cats were fasted 12 h prior to blood sampling.
Hematology tubes containing EDTA were stored at + 4 °
C and analyzed the same day to obtain red blood cells
(RBC), white blood cells (WBC), hematocrit (Hct), and
hemoglobin (Hb) values. Tubes without anticlotting
agents were immediately centrifuged at 1500 g for 10
min. Serum was divided into two aliquots of a minimum
0.5 ml each and stored in plastic flasks resistant to freez-
ing at − 20 °C until processing. The first aliquot was used
for biochemical analysis (albumin, ALB; blood urea ni-
trogen, BUN; creatinine, CREA; alanine-amino transfer-
ase, ALT; glucose) and TT4; the second aliquot used to
assess the redox status, was processed within 3 months
[27, 30]. TT4 concentrations were measured by chemilu-
minescence (Catalyst Total T4 assay run on the IDEXX
Catalyst One analyse). TT4 > 54 nmol/L or 4.3 μg/dL
was considered consistent with hyperthyroidism. Deter-
minable reactive oxygen metabolites (d-ROMs) were
quantified using the d-ROMs Test (Diacron Inter-
national Srl, Grosseto, Italy) as an indicator of oxidative
stress due to free radicals. Antioxidant status was esti-
mated using the OXY-Adsorbent Test (Diacron Inter-
national) to quantify the plasma barrier to oxidation.
The Oxidative Stress index (OSi) was calculated by the
ratio of the d-ROMs test result to the OXY-Adsorbent
test result [25–27, 30]. The assays used in this study had
been previously used in cats by Castillo et al. [30], but
data about their validation in the feline species were not
available. A validation study for the use of d-ROMs test
and OXY-Adsorbent test on cat sera was performed, ac-
cording to a protocol modified from Pasquini et al., [31].
The within-run precision was estimated by calculating
the intra-assay Coefficient of Variation (CV) on the basis
of the results obtained after performing the tests in 12
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samples repeated 3 times. Between-run precision was
evaluated by assessing the inter-assay CV using the re-
sults obtained from 12 samples repeated 2 times. The
linearity was assessed using two serum samples, the first
one for d-ROMs test (264 Carr U) and the second one
for OXY-Adsorbent test (473 μmol HClO/ml). Samples
were diluted 1:1, 1:2, 1:4 and 1:8 in bi-distilled water and
tested. A correlation analysis was used to examine the
relationship results of diluted samples and expected re-
sults and the Coefficient of Regression (R2) was
calculated.
Moreover, in order to confirm stability of dROMs and
OXY-Adsorbent values during long-term storage at − 20
°C [27, 30] a validation study was performed. Briefly, 7
cat samples were utilized to evaluate the conservation.
Tests were run immediately after the venipuncture (A),
after 3-month freezing (− 20 °C), (B) and after 6-month
freezing (− 20 °C), (C). In B and C, serum was defrosted
at room temperature. Coefficient of Variation (CV) for
A vs B, A vs C, and for B vs C was calculated.
Statistical analysis
All haemato-biochemical parameters, TT4 values and
redox status markers were checked for normal distribu-
tion, before applying parametric tests. In order to
neutralize the possible interference of age, gender, BCS as
comparing dROMs, OXY-Adsorbent and Osi values in
Group H, I and C, different subgroups were preliminarily
identified. The following criteria were adopted:
age-subgroups were classified according to AAFP-AAHA
guidelines [32], as mature (cats within the age interval of
6–10 years), senior (cats within the age interval of 11–14
years) and geriatric (cats elder then 15 years).
Sex-subgroups comprehended male (M), female (F), cas-
trated male (CM) and neutered female (NF) cats.
BCS-subgroups were classified according to WSAVA
guidelines [28] as under ideal (cats with a BCS of 1–3 out
of 9), ideal (cats with a BCS of 5 out of 9) and over ideal
(cats with a BCS of 6–9 out of 9). To identify correlations
between d-ROMs, OXY-Adsorbent, Osi and covariates
considered (age, sex, BCS, selected haemato-biochemical
parameters such as RBC, WBC, HCT, Hb, BUN, Crea,
Alb, ALT and GLU), a preliminary statistical analysis was
performed. A quantile multivariate regression model was
applied using the software StataCorp. 2015 (Stata: Release
14. Statistical Software. College Station, TX: StataCorp
LP). The statistical significance was set at 5% level
(p < 0.05). Age, sex and BCS didn’t significantly influenced
dROMs, OXY-Adsorbent and Osi values when comparing
subgroups of Group H, Group I and Group C (p > 0.05;
Additional file 1: Table S2). No significant correlation was
seen between Albumin, dROMs and OXY, while Albumin
and BUN were negatively, but significant correlated with
Osi (p < 0.05 and p < 0.001, respectively; Additional file 1:
Table S3). Given the above, a possible interference be-
tween d-ROMs, OXY-Adsorbent, Osi and covariates iden-
tified was considered irrelevant; then, data were simply
compared between hyperthyroid, chronically ill and
healthy cats (without subgroups) using ANOVA with
Tukey’s multiple comparisons test Statistical analysis was
performed using GraphPad Prism 7.04 (GraphPad soft-
ware, CA, USA). Significance was set at 5% (p < 0.05).
Results
Of the 180 cats assessed during recruitment, 154 were
deemed eligible for enrollment in the study, matching all
inclusion criteria and having a complete clinical and nu-
tritional history. Furthermore, 30 of the 154 serum sam-
ples stored for redox status assessment were discarded
before analysis because of flocculation, defrosting or
hemolysis, leaving complete data for 124 cats. Signal-
ment of cats included in the three groups and their sub-
groups are reported in Table 1. Haemato-biochemical
parameters, including serum TT4 concentration, are
presented in Table 2.
The domestic short-hair breed made up almost 90% of
the cats recruited. The predominant gender was the
male one in the diseased population (62.5% in group H
and 66.8% in group I, respectively), while sex distribu-
tion was more homogeneous in the control group.
Although mature, senior and geriatric cats were pur-
posefully recruited as controls cats, the hyperthyroid
population was significantly older (mean age of 12.9 ±
3.1 years) as compared to healthy and chronically ill cats
(9.9 ± 2.0 years and 10.4 ± 3.3 years respectively, p < 0.01
and p < 0.05; Table 1). Hyperthyroid cats also had signifi-
cantly lower body weight and body condition score com-
pared to groups C and I (p < 0.01 and p < 0.05,
respectively; Table 1). Diseases diagnosed in cats in-
cluded in group I are given in Table 1. The predominant
illness was a chronic infectious or inflammatory condi-
tion (35.6% of all chronically ill cats).
When considering haemato-biochemical parameters,
group H had significantly lower serum albumin concen-
tration and higher serum glucose concentration than
healthy cats (p < 0.05; Table 2) and a greater hepatocellu-
lar damage as compared to healthy and diseased cats
(p < 0.01 and p < 0.05, respectively; Table 2). Results of
other serum parameters fitted with criteria of inclusion
established for the study. For instance, the serum TT4
concentration of group H was significantly higher as
compared to groups I and C (p < 0.01 and p < 0.05, re-
spectively). Chronically ill patients (group I) had signifi-
cantly higher WBC count as compared to the other two
groups (p < 0.01), due to the enrollment of patients af-
fected from infectious/inflammatory diseases, and a
greater impairment (p < 0.05) of renal function due to
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the inclusion of cats diagnosed with CKD IRIS stage ≥2,
(Table 2).
As for oxidative stress markers, intra-assay and
inter-assay coefficients of variation (CV) for dROMs test
were 1.91 and 1.72%, respectively, with a coefficient of
linear regression (R2) of 0.99. Intra-assay and inter-assay
CV for OXY-Adsorbent were 1.76 and 1.45 with R2 =
0.98, (Additional file 1: Table S1). As regard stability
after prolonged storage, the CVs for dROMs between
group A and B, between group A and C and between
group B and C were 3.4, 5.8% and 1.9, respectively. The
CVs for OXY-Adsorbent test between group A and B,
between group A and C and between group B and C
were 3.47, 4.7% and 1.12, respectively. Determinable re-
active oxygen metabolites (dROMs) of the hyperthyroid
cats (193 ± 47 CarrU) were significantly higher (p <
0.001) than those of the healthy cats (103 ± 17 CarrU),
and although the dROMs of group I (185 ± 45 CarrU)
were lower than in group H, this difference was not sig-
nificant (Fig. 1). The OXY-Adsorbent test results in the
hyperthyroid cats (265 ± 68 μmol HClO/ml) were signifi-
cantly lower than those in healthy cats (390 ± 83 μmol
Table 1 Signalment and diseases diagnosed in cats included in groups C, I and H
Group C (39 cats) Group I (45 cats) Group H (40 cats)
Age (years) 9.9 ± 2.0 α 10.4 ± 3.3 α 12.9 ± 3.1 β
Sex (%) 5.2 F
46.1 NF
20.5 M
28.2 MC
4.3 F
28.9 NF
6.8 M
60 MC
37.5 NF
62.5 MC
Predominant Breed (%) 89.7 DSH 84.5 DSH 90 DSH
Other breeds (%) 5.1 Sphynx
2.6 Chartreaux
2.6 Devon Rex
8.9 Persian
2.2 British short hair
2.2 Devon rex
2.2 Siamese
5 Persian
2.5 Siamese
2.5 Maine Coon
Body weight (Kg) 4.9 ± 1 α 4.9 ± 1.6 α 4.2 ± 1.2 β
BCS (1–9 scale) 5 ± 1 α 4.8 ± 1.6 α 4 ± 1 β
Diseases diagnosed n and (%) / Infectious/Inflammatory
16 (35.6)
CKD
14 (31.1)
Metabolic
6 (13.3)
Neoplastic
8 (17.8)
Other
1 (2.2)
Hyperthyroidism
Signalment and diseases diagnosed in cats included in groups C, I and H. Data are expressed as Mean ± Standard deviation or Percentage (%)
BCS Body condition score, DSH domestic short hair, M male, F female, MC male castrated, NF neutered female, n = number of cats
Data were compared by ANOVA with Tukey’s multiple comparisons post-test. Different symbols (α, β) indicate differences between groups (p < 0.05)
Table 2 Haemato-biochemical parameters of groups C, I and H
Selected haemato-biochemical parameters Group C (39 cats) Group I (45 cats) Group H (40 cats) Reference range
TT4 (nmol/L); (μg/dL ± Sd) 25.7 nmol/L 28.3 nmol/L 106 nmol/L 10.3–54
2 ± 0.5 μg/dL α 2.2 ± 0.6 μg/dL α 8.3 ± 4.2 μg/dL β nmol/L; 8–4.2 μg/dL
Alb (g/dL) 3.6 ± 0.6 α 3.4 ± 1.1 αβ 3.1 ± 0.6 β 2.2–4.4
BUN (mg/dL) 21 ± 4.9 α 51 ± 26 β 33 ± 8.7 α 10–30
Crea (mg/dL) 1.2 ± 0.2 α 2.6 ± 2.5 β 1.5 ± 0.8 α 0.3–1.6
Glucose (mg/dL) 106 ± 26 α 151 ± 88 β 147 ± 27 β 70–150
ALT (IU/L) 75 ± 22 α 118 ± 107 αβ 148 ± 129 γ 20–100
RBC × 106 (/uL) 5.9 ± 1.3 6.6 ± 1.4 6.7 ± 1.7 4.6–10.0
Hct (%) 36 ± 5 37 ± 6 35 ± 7 28–49
WBC × 103 (/uL) 9.9 ± 3.6 α 18.6 ± 9.9 β 10.1 ± 3.3 α 5.5–19.5
Selected haemato-biochemical parameters of groups C, I and H. Data are given as Mean ± Standard Deviation
Alb albumin, ALT alanine-amino transferase, BUN blood urea nitrogen, Crea creatinine, Hct haematocrit, RBC red blood cells, TT4 serum total tetraiodothyroxine,
WBC white blood cells
Data were compared by ANOVA with Tukey’s multiple comparisons post-test. Different symbols (α, β, γ) indicate differences between groups (p < 0.05)
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HClO/ml; p < 0.01) and chronically ill cats (306 ±
45 μmol HClO/ml, p < 0.05) (Fig. 2). Moreover, the Osi
value in group H (0.8 ± 0.2 CarrU/μmol HClO/ml) was
significantly higher (p < 0.001) than that of the healthy
cats (0.3 ± 0.1 CarrU/μmol HClO/ml), and although the
Osi value in group H was higher than in group I (0.6 ±
0.1 CarrU/μmol HClO/ml), this difference was not sig-
nificant (Fig. 3).
Discussion
Feline hyperthyroidism is recognized as the most com-
mon endocrine disease in mature cats. Although its etio-
pathogenesis remains unclear [2, 3], it resembles human
thyrotoxic syndromes [3] in which redox unbalance has
been previously described as playing a role in the sever-
ity of clinical signs [10, 11] and in idiosyncratic drug re-
actions [13–15]. Therefore, we assumed that
hyperthyroid cats could also develop a redox unbalance,
as compared to healthy cats or cats with chronic
non-thyroidal illness. The cohort of hyperthyroid cats
recruited for the current study was in line with the
population of hyperthyroid cats described in the litera-
ture. Signalment and haemato-biochemical values of our
hyperthyroid population were harmonized with those in
recent trials [4, 31], and overlapped with the cohort in-
vestigated by Branter et al. [25] who evaluated the anti-
oxidant status of hyperthyroid cats before and after
radioiodine treatment. Moreover, the healthy population
was quite comparable to the group referred to as A2
(healthy cats with an age ranging from 7 to 12 years) in
the study from Castillo et al. [30] and to the control
group from Branter et al. [25]. However, age tended to
be higher than Castillo et al. [30], with regard to the ill
and hyperthyroid group and their results suggest that
dROMs values tends to decrease with ageing, which
could suggest that oxidative stress is even more pro-
nounced in the hyperthyroid cats then in other categor-
ies. The impact of gender (≈50% of F in the control
group vs ≈ 40% of F in the ill and hyperthyroid group)
could also have skewed the results. However, considering
preliminarily results obtained from the regression model
as comparing age-subgroups, sex-subgroups and
BCS-subgroups, the possible influence of aforemen-
tioned covariates seems to be negligible. In the present
study, then, redox unbalance was mainly influenced
from the status of disease rather from other parameters
considered.
Fig. 1 Box-and-whisker plot of dROMs (determinable reactive
oxygen metabolites) values in Groups C, H and I. The median is
indicated by a horizontal line, the boxes indicate the second and
third quartile, and the whiskers include 95% of the data. Different
symbols (α, β) indicate differences between groups (p < 0.05)
Fig. 2 Box-and-whisker plot of OXY-Adsorbent values in Groups C, H
and I. The median is indicated by a horizontal line, the boxes
indicate the second and third quartile, and the whiskers include 95%
of the data. Different symbols (α, β, γ) indicate differences between
groups (p < 0.05)
Fig. 3 Box-and-whisker plot of OSi (oxidative stress index) values in
Groups C, H and I. The median is indicated by a horizontal line, the
boxes indicate the second and third quartile, and the whiskers
include 95% of the data. Different symbols (α, β) indicate differences
between groups (p < 0.05)
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Reactive oxygen metabolites (dROMs) and OSi values
were higher in hyperthyroid cats than in healthy cats, in-
dicating that thyrotoxicosis may affect the redox balance,
as described in humans and laboratory animals [8, 9].
Furthermore, although a significant increase in redox
unbalance (increased dROMs and OSi values and de-
creased OXY-adsorbent test results) was observed also
in the cats with other chronic diseases (Group I), the
hyperthyroid population (group H) had the greatest im-
pairment of antioxidant defences (i.e., a greater decrease
in OXY-Adsorbent values). This result seems to be in
contrast with the study from Branter et al. [25] where
urinary 8-isoprostanes (markers of oxidative stress) were
significantly increased in hyperthyroid cats, even though
circulating blood antioxidants were not depleted [25].
Thirty of the 44 hyperthyroid cats enrolled in the afore-
mentioned trial, however, had been treated previously
with methimazole, and had discontinued the drug a me-
dian of 12.5 days before evaluation. Moreover, only a
small number of cats had documented prior idiosyn-
cratic adverse reactions. Given the above, it is possible
that the short discontinuation interval together with the
low-rate occurrence of methimazole-related side effects
had interfered with their antioxidant status.
Based on our findings, hyperthyroid cats may be spe-
cifically identified as possible candidates for nutritional
supplementation with antioxidants during medical treat-
ment for hyperthyroidism, with the dual goal of reducing
the gap between overproduction of free radicals (due to
the hypermetabolic state) and the decreased serum anti-
oxidant status. The decrease in serum antioxidant levels
in our cohort could be related to either progressive ex-
haustion of serum antioxidant capacity due to chronic
challenge or reduced absorption/increased loss of anti-
oxidant compounds through the small bowel and kid-
neys. It would be useful to evaluate the activity of
endogenous antioxidant enzymes (e.g. SOD, CAT and
GPx) in such a group in a future trial. Our present re-
sults are not able to elucidate the mechanism underlying
the redox unbalance in hyperthyroid cats.
The general increase in oxidative stress markers dur-
ing chronic illness detected in the current study is
shared by previous studies [18–24], but a reliable com-
parison with the diseased population from literature
could not be performed due to heterogeneity in signal-
ment and type of illnesses considered.
Moreover, we used different assays to quantify free rad-
ical production. This constitutes a crucial aspect of redox
balance assessment in veterinary medicine: there is no
unique, standardized method that describes oxidative
stress and antioxidant status in feline disease [27], which
hampers an accurate comparison across trials and the
identification of species-specific reference ranges [30, 31,
33, 34]. To date, only one short communication has been
published in which dROMs and OXY-Adsorbent tests to
assess oxidative stress and antioxidant status in healthy
cats were described [30], while studies generally report
findings in other species like dog and humans [33, 34].
Our data, however, seem to support the use of dROMs,
OXY-Adsorbent and OSi as possible markers of redox sta-
tus in the feline species, also after prolonged storage of
serum samples at − 20 °C. However, our data support the
use of dROMs, OXY-Adsorbent and OSi as possible
markers of redox status in the feline species, even after
storage of serum samples at − 20 °C for 3months.
Pasquini et al. [31] found that dROMs values ranged
from 56 to 91 CarrU in Labrador dogs, while a mean
dROMs value of 396 CarrU and a mean OXY-Adsorbent
value of 416 μmol HClO/ml were reported in healthy
humans [34]. This means that physiological levels of free
radicals in feline plasma (a mean dROMs of 103 CarrU
in our healthy population and a mean of 126 CarrU in
the population [cats > 7 years] studied by Castillo et al.)
[30], fall somewhere in between the normal levels in
dogs and humans. Species-specific differences in the
mechanisms counteracting oxidative stress damage are
likely to exist and need to be considered when develop-
ing translational models of diseases.
The limitations of the present study are the
non-standardized diet and the non-standardized definition
of disease type in group I that could have interfered with
redox status. Despite preliminarily data obtained from the
multivariate analysis, the lack of age matching,
sex-matching and BCS-matching groups could also repre-
sent a possible confounding factor, still. Further studies in
a more controlled setting are warranted to confirm our
findings and to address these possible biases. Moreover,
the study of redox unbalance before and after hyperthy-
roidism treatment would also have strengthened our find-
ings. Given the above, a double-blind, placebo controlled,
randomized clinical trial evaluating the effect of methima-
zole alone or in combination with antioxidant supplemen-
tation is ongoing at the time of manuscript’s drafting.
Conclusion
The present study showed for the first time that, as pre-
viously described in hyperthyroid humans, redox unbal-
ance can be determined in hyperthyroid cats and that
cats may provide a spontaneous animal model for oxida-
tive stress-related studies linked to thyrotoxicosis. Fur-
thermore, our findings could also have a potential
clinical application, where early diagnosis and treatment
of the disease, as well as reducing drug-related side ef-
fects, are the key-factors in successful treatment out-
come. Given the role of redox unbalance in the course
of FH, clinical trials investigating the potential positive
effects of antioxidant supplementation in hyperthyroid
cats are desirable.
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Additional file
Additional file 1: Table S1. Validation data for dROMs and OXY-
Adsorbent assays on feline serum collected by authors and their comparison
with DIACRON® and Pasquini et al., 2008. Table S2. Preliminary statistical
analysis with the quantile multivariate regression model. Correlations be-
tween d-ROMs, OXY-Adsorbent, Osi and age, gender and BCS. Table S3.
Preliminary statistical analysis with the quantile multivariate regression
model. Correlations between d-ROMs, OXY-Adsorbent, Osi and selected
haemato-biochemical parameters (BCS, RBC, WBC, Hct, Hb, BUN, Crea, Alb,
ALT and GLU). (DOCX 23 kb)
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